Vicki Kelemen serves as Executive at Cardiff Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Vicki Kelemen has executed 5 insider transactions totaling $666.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 23, 2021 involved purchasing 960 shares valued at $9.9K.
Vicki Kelemen currently holds 6,053 shares of Cardiff Oncology, Inc. (CRDF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vicki Kelemen has been a net seller of CRDF stock. They have purchased $9.9K and sold $657.0K worth of shares.
Vicki Kelemen's most recent insider trade was on Mar 23, 2021, when they purchased 960 shares at $10.31 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 2, 2021 | CRDF | $0 | Option Exercise | 70 | $N/A | Discretionary |
| Nov 23, 2020 | CRDF | $657.0K | Sale | 35,321 | $18.60 | Discretionary |
| Nov 23, 2020 | CRDF | $87.6K | Option Exercise | 35,321 | $2.48 | Discretionary |